In This Section

Program

Workshop Sessions

This is an intensive workshop providing a substantive overview of key areas in molecular biology, translational cancer research, current lab techniques, career development, and the best practices of grant writing for the aspiring physician-scientist.

Lectures

Our faculty experts will give overview lectures on key areas of translational cancer research, using examples of their research to demonstrate the process of developing experiments to interrogate hypothesis-driven scientific questions. Lecture faculty will facilitate stimulating discussion and will integrate career development advice through personal examples from their career paths.

Laboratories

Our laboratory faculty will run three laboratory sessions consisting of an overview and skills application in NextGen Sequencing, RNA Seq and Bioinformatics, and CRISPR. These labs are conducted in small groups to maximize the learning experience and faculty interaction.

Career Development and Mentoring

Participants will also benefit from sessions on career development with several opportunities for small group discussions with the faculty, larger panel discussions, and open discussion during lecture sessions.

Guidance in Grant Writing

The Workshop begins with a comprehensive lecture on the best practices of grant writing. Over the week, participants will develop the specific aims of an imminent grant, career development award, or future proposed research project (submitted one week prior to the workshop). Small groups of two to three participants and a faculty mentor will examine the hypothesis and aims and refine their work over the week using the best practices presented.

Program

Monday, July 19, 2021

Welcome and Introductions
10-10:30 a.m.

†not eligible for CME credit

Lecture Session 1
10:30 a.m.-12 p.m.

Break
12-1 p.m.

Tutorial: Principles of Grant Writing
1-2 p.m.

Break
2-2:30 p.m.

Grant Writing Project: Specific Aims Group 1, Session 1
2:30-4 p.m.

Break
4-4:30 p.m.

Small Group Discussions with Faculty
4:30-6 p.m.

Tuesday, July 20, 2021

Laboratory Rotation 1
10 a.m.-12 p.m.

Break
12-1 p.m.

Lecture Session 2
1-2:30 p.m.

Break
2:30-3 p.m.

Grant Writing Project: Specific Aims Group 1, Session 2
3-4:30 p.m.

Break
4:30-5 p.m.

Panel Discussion: Physician-Scientists in Industry
5-6:30 p.m.

Wednesday, July 21, 2021

Lecture Session 3
10-11:30 a.m.

Break
11:30 a.m.-12:30 p.m.

Laboratory Rotation 2
12:30-2:30 p.m.

Break
2:30-4 p.m.

Small Group Discussions with Faculty
4-5:30 p.m.

Thursday, July 22, 2021

Laboratory Rotation 3
10 a.m.-12 p.m.

Break
12-1 p.m.

Lecture Session 4
1-2:30 p.m.

Break
2:30-3 p.m.

Grant Writing Project: Specific Aims Group 2, Session 1
3-4:30 p.m.

Break
4:30-5 p.m.

Responsible Conduct of Research Lecture and Discussion
5-5:45 p.m.

Friday, Juily 23, 2021

Lecture Session 5
10-11:30 a.m.

Break
11:30 a.m.-1 p.m.

Grant Writing Project: Specific Aims Group 2, Session 2
1-2:30 p.m.

Break
2:30-4 p.m.

Wrap-Up/Closing Panel Discussion
4-5:30 p.m.

Lecture Faculty

Mark W. Geraci, University of Pittsburgh, Pittsburgh, Pennsylvania
Carl H. June, Perelman School of Medicine University of Pennsylvania, Philadelphia, Pennsylvania
William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, Massachusetts
David G. Kirsch, Duke University Medical Center, Durham, North Carolina
Ross L. Levine, Memorial Sloan Kettering Cancer Center, New York, New York
Christine M. Lovly, Vanderbilt University Medical Center, Nashville, Tennessee
W. Kimryn Rathmell, Vanderbilt University Medical Center, Nashville, Tennessee
Charles L. Sawyers, Memorial Sloan Kettering Cancer Center, New York, New York
Jean Y. Tang, Stanford University School of Medicine, Redwood City, California
Jennifer A. Wargo, The University of Texas MD Anderson Cancer Center, Houston, Texas

Panelists

Jeffrey A. Engelman, Treeline Biosciences, Watertown, Massachusetts
W. Nicholas Haining, Merck & Co., Inc., Boston, Massachusetts
William Pao, Roche Applied Science, Basel, Switzerland

Lab Faculty

Next-Generation Sequencing: An Introduction and Applications for Oncology

Camilla Heinzmann, Heinzmann Coaching and Consulting, Inc., Valencia, California
Maggie Soares, Heinzmann Coaching and Consulting, Inc., Toronto, ON, Canada

RNA-seq Analysis in Cancer Biomarker Discovery and Network Interpretation

Tzu Phang, University of Colorado Anschutz Medical Campus, Aurora, Colorado
Robert Stearman, Indiana University School of Medicine, Indianapolis, Indiana

CRISPR: The Genome-Editing Revolution

Leigh P. Brody, UCL Technology Fund at Albion VC, London, United Kingdom